|
|
Other links at Articles > Rheumatology |
| 1. |
Methotrexate Pharmacokinetics Point Toward Possible Alternative Dosing
|
|
|
In patients with rheumatoid arthritis (RA), it can take 6 months for oral methotrexate (MTX) to reach steady-state blood levels, according to a study by researchers in New Zealand published in the November issue of Arthritis & Rheumatism. The authors also found that in patients who had discontinued MTX, elimination of the drug from red blood cells was also slow. Reuters Health Information
|
| 4. |
Update on New Therapies in SLE
|
|
|
Current lupus therapies are suboptimal and associated with concerning adverse events. Drs. Stephen Paget and Kyriakos Kirou discuss the recent wave of potential new SLE therapies that are under investigation. Medscape Rheumatology
|
| 5. |
Risk of Blood Cancer Increased in Lupus Patients
|
|
|
Results of a new study provide more evidence that immunosuppressive drug therapy may contribute to an increased risk of hematologic malignancies in patients with systemic lupus erythematosus (SLE). Reuters Health Information
|
|
|
